HPCM
ANAB icon

Hunter Perkins Capital Management’s AnaptysBio ANAB Stock Holding History

Hunter Perkins Capital Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-9,130
Closed -$317K – 84
2021
Q4 		$317K Hold
9,130
– – 0.06% 72
2021
Q3 		$248K Hold
9,130
– – 0.05% 71
2021
Q2 		$237K Buy
+9,130
New +$219K 0.04% 80

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Hunter Perkins Capital Management's ANAB Position: Q1 2022 in Review

Hunter Perkins Capital Management sold out of AnaptysBio (ANAB) in Q1 2022, closing a stake of 9,130 shares — an estimated $317K sold.

Hunter Perkins Capital Management first reported a position in ANAB in Q2 2021 and held it in 3 quarters. The position peaked at $317K in Q4 2021. 131 funds tracked by Wall St. Rank hold ANAB as of Q1 2022.

  • Hunter Perkins Capital Management reported no remaining AnaptysBio position as of Q1 2022 after selling out during the quarter.
  • Hunter Perkins Capital Management sold 9,130 AnaptysBio shares in Q1 2022, an estimated $317K.
  • Hunter Perkins Capital Management first reported a position in AnaptysBio in Q2 2021 and held it in 3 quarters.
  • Hunter Perkins Capital Management's AnaptysBio position peaked at $317K in Q4 2021.
  • 131 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2022.

Based on Hunter Perkins Capital Management's 13F filing for Q1 2022, filed 27 Apr 2022.